235 related articles for article (PubMed ID: 25667231)
21. Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital.
Popiel KY; Miller MA
Infect Control Hosp Epidemiol; 2014 Jul; 35(7):818-25. PubMed ID: 24915209
[TBL] [Abstract][Full Text] [Related]
22. Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital.
Sohn KM; Peck KR; Joo EJ; Ha YE; Kang CI; Chung DR; Lee NY; Song JH
Int J Infect Dis; 2013 Apr; 17(4):e240-6. PubMed ID: 23195640
[TBL] [Abstract][Full Text] [Related]
23. [Vancomycin resistant enterococci in the Netherlands].
Leavis HL; Willems RJ; Mascini EM; Vandenbroucke-Grauls CM; Bonten MJ
Ned Tijdschr Geneeskd; 2004 May; 148(18):878-82. PubMed ID: 15152389
[TBL] [Abstract][Full Text] [Related]
24. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment.
Zirakzadeh A; Patel R
Mayo Clin Proc; 2006 Apr; 81(4):529-36. PubMed ID: 16610573
[TBL] [Abstract][Full Text] [Related]
25. Rapid gastrointestinal loss of Clostridial Clusters IV and XIVa in the ICU associates with an expansion of gut pathogens.
Livanos AE; Snider EJ; Whittier S; Chong DH; Wang TC; Abrams JA; Freedberg DE
PLoS One; 2018; 13(8):e0200322. PubMed ID: 30067768
[TBL] [Abstract][Full Text] [Related]
26. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract.
Donskey CJ; Hanrahan JA; Hutton RA; Rice LB
J Infect Dis; 1999 Aug; 180(2):384-90. PubMed ID: 10395853
[TBL] [Abstract][Full Text] [Related]
27. A probiotic Lactobacillus strain can acquire vancomycin resistance during digestive transit in mice.
Mater DD; Langella P; Corthier G; Flores MJ
J Mol Microbiol Biotechnol; 2008; 14(1-3):123-7. PubMed ID: 17957119
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
Zhanel GG; Laing NM; Nichol KA; Palatnick LP; Noreddin A; Hisanaga T; Johnson JL; Hoban DJ;
J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592
[TBL] [Abstract][Full Text] [Related]
29. Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract.
Donskey CJ; Hanrahan JA; Hutton RA; Rice LB
J Infect Dis; 2000 May; 181(5):1830-3. PubMed ID: 10823795
[TBL] [Abstract][Full Text] [Related]
30.
Zhang W; Zhu B; Xu J; Liu Y; Qiu E; Li Z; Li Z; He Y; Zhou H; Bai Y; Zhi F
Front Immunol; 2018; 9():1040. PubMed ID: 29868005
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic options for vancomycin-resistant enterococcal bacteremia.
Barber KE; King ST; Stover KR; Pogue JM
Expert Rev Anti Infect Ther; 2015 Mar; 13(3):363-77. PubMed ID: 25661903
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey].
Yiş R; Aslan S; Cıtak C; Değirmenci S
Mikrobiyol Bul; 2011 Oct; 45(4):646-54. PubMed ID: 22090295
[TBL] [Abstract][Full Text] [Related]
33. [Vancomycin resistant enterococci in Austria].
Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
[TBL] [Abstract][Full Text] [Related]
34. Fecal microbiota transplantation prevents Candida albicans from colonizing the gastrointestinal tract.
Matsuo K; Haku A; Bi B; Takahashi H; Kamada N; Yaguchi T; Saijo S; Yoneyama M; Goto Y
Microbiol Immunol; 2019 May; 63(5):155-163. PubMed ID: 30919462
[TBL] [Abstract][Full Text] [Related]
35. Vancomycin-resistant-enterococci--colonization of 24 patients on a pediatric oncology unit.
Schuster F; Graubner UB; Schmid I; Weiss M; Belohradsky BH
Klin Padiatr; 1998; 210(4):261-3. PubMed ID: 9743963
[TBL] [Abstract][Full Text] [Related]
36. Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice.
Grazul H; Kanda LL; Gondek D
Gut Microbes; 2016; 7(2):101-14. PubMed ID: 26963277
[TBL] [Abstract][Full Text] [Related]
37. [Vancomycin-resistant enterococci: prevalence and factors associated with intestinal colonization in oncology patients from Hospital de Niños de Córdoba].
Reale AL; Depetri ML; Culasso C; Paviolo M; Cheguirián ML; Enrico MC; Ledesma EM; Vidal C; Glatstein E; Bertoni L
Rev Argent Microbiol; 2009; 41(2):92-6. PubMed ID: 19623898
[TBL] [Abstract][Full Text] [Related]
38. Vancomycin-resistant enterococci: why are they here, and where do they come from?
Bonten MJ; Willems R; Weinstein RA
Lancet Infect Dis; 2001 Dec; 1(5):314-25. PubMed ID: 11871804
[TBL] [Abstract][Full Text] [Related]
39. Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection.
Miller M; Bernard L; Thompson M; Grima D; Pepin J
Infect Control Hosp Epidemiol; 2010 Jul; 31(7):710-5. PubMed ID: 20518636
[TBL] [Abstract][Full Text] [Related]
40. Outbreak of vancomycin-resistant enterococci in a burn unit.
Falk PS; Winnike J; Woodmansee C; Desai M; Mayhall CG
Infect Control Hosp Epidemiol; 2000 Sep; 21(9):575-82. PubMed ID: 11001260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
